SAMIK PHARM. recorded a single insider transaction recently, involving a sale of 20,000 shares by an executive valued at 220 million KRW. This divestment occurred amidst a 79.2% stock price increase over the past ninety days. No further activity or upcoming earnings report details are currently available for this micro-cap entity.